‌

US Patent 10772959 Stable aqueous formulations of adalimumab

Patent 10772959 was granted and assigned to Coherus BioSciences on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Coherus BioSciences

Current Assignee

Coherus BioSciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10772959

Date of Patent

September 15, 2020

Patent Application Number

16023046

Date Filed

June 29, 2018

Patent Citations

‌

US Patent 10195275 Stable aqueous formulations of adalimumab

‌

US Patent 10155039 Stable aqueous formulations of adalimumab

‌

US Patent 10159732 Stable aqueous formulations of adalimumab

‌

US Patent 10159733 Stable aqueous formulations of adalimumab

‌

US Patent 10207000 Stable aqueous formulations of adalimumab

Patent Primary Examiner

‌

Yunsoo Kim

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10772959 Stable aqueous formulations of adalimumab

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API